Advocacy in Neuropsychology

Regular price €55.99
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Advocacy 101
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Laura L.S. Howe
B01=Neil Pliskin
Board Certification
Category1=Non-Fiction
Category=JMM
clinical brain assessment
Clinical Neuropsychology
competency in psychological practice
COP=United Kingdom
Delivery_Pre-order
Demonstrated Clinical Skills
diversity in mental health
Epilepsy
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_society-politics
health policy psychology
Language_English
outcome studies neuropsychology
PA=Temporarily unavailable
Price_€20 to €50
professional identity development
PS=Active
public sector neuropsychology advocacy
Sample legislation
softlaunch

Product details

  • ISBN 9781848727298
  • Weight: 320g
  • Dimensions: 175 x 250mm
  • Publication Date: 16 Apr 2010
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: GB
  • Product Form: Paperback
  • Language: English
Secure checkout Fast Shipping Easy returns

There are critical issues facing the neuropsychological community, such as inadequate reimbursement for services, a lack of familiarity among public policy makers regarding the science and practice of neuropsychology, and a lack of public policy awareness among professional neuropsychologists. Advocacy for the field is the most effective way to undertake positive change. Currently, a minority of psychological professionals actively engages in an advocacy process. With weak advocacy, our field risks slower development in key areas and without strong and constant advocacy, we risk losing ground previously gained. The purpose of this special issue of The Clinical Neuropsychologist, is to: (1) convey the importance of advocacy, (2) address and dispel unfounded mental obstacles that inhibit involvement in advocating for the specialty, and (3) aid neuropsychologists in preparing to join the advocacy process.

A primary motivation to engage in advocacy should be found in the stark realization that most critical decisions that affect neuropsychological practice are made by non-neuropsychologists. The twelve articles in this issue address topics such as increasing the public’s awareness of neuropsychology, how to advocate for neuropsychology in the government sector, how to advocate for specific patient populations, promotion of professional identity and scope of practice, advancement of the science of the field, select issues at the interface of neuropsychology and the law, increasing the diversity of neuropsychological practitioners, and increasing services to underserved populations. It is our hope that this special issue will be a catalyst for positive change.

VA Palo Alto Health Care System, USA University of Illinois College of Medicine, USA